36.27
price up icon1.95%   0.695
after-market After Hours: 36.28 0.005 +0.01%
loading
Simulations Plus Inc stock is traded at $36.27, with a volume of 152.37K. It is up +1.95% in the last 24 hours and up +19.36% over the past month. Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
See More
Previous Close:
$35.58
Open:
$35.58
24h Volume:
152.37K
Relative Volume:
0.67
Market Cap:
$718.91M
Revenue:
$66.98M
Net Income/Loss:
$9.65M
P/E Ratio:
75.57
EPS:
0.48
Net Cash Flow:
$10.19M
1W Performance:
+5.70%
1M Performance:
+19.36%
6M Performance:
-0.70%
1Y Performance:
-5.88%
1-Day Range:
Value
$35.35
$36.33
1-Week Range:
Value
$33.09
$36.62
52-Week Range:
Value
$24.00
$51.22

Simulations Plus Inc Stock (SLP) Company Profile

Name
Name
Simulations Plus Inc
Name
Phone
661-723-7723
Name
Address
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Name
Employee
247
Name
Next Earnings Date
2025-01-07
Name
Latest SEC Filings
Name
SLP's Discussions on Twitter

Compare SLP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
SLP
Simulations Plus Inc
36.27 718.91M 66.98M 9.65M 10.19M 0.48
Health Information Services icon
VEEV
Veeva Systems Inc
237.20 38.43B 2.66B 665.91M 1.08B 4.05
Health Information Services icon
DOCS
Doximity Inc
79.23 14.73B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
SOLV
Solventum Corp
73.38 12.59B 8.26B 66.00M 1.17B 0.3682
Health Information Services icon
TEM
Tempus Ai Inc
68.96 10.57B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
111.52 9.69B 1.15B 96.70M -161.99M 1.09

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-15-24 Initiated Stephens Overweight
Jul-29-24 Initiated KeyBanc Capital Markets Overweight
Jul-16-24 Initiated JMP Securities Mkt Perform
Jun-28-24 Initiated William Blair Outperform
May-09-23 Initiated BTIG Research Buy
Oct-26-21 Upgrade Craig Hallum Hold → Buy
Jan-12-21 Downgrade Craig Hallum Buy → Hold
Oct-16-20 Initiated Raymond James Outperform
Sep-08-20 Initiated Oppenheimer Outperform
Jan-06-20 Initiated Craig Hallum Buy
View All

Simulations Plus Inc Stock (SLP) Latest News

pulisher
Feb 06, 2025

Conestoga Capital Advisors LLC Purchases 290,414 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Short Interest Up 29.1% in January - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Buy" by Analysts - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Insider Sell: Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) - GuruFocus.com

Feb 04, 2025
pulisher
Feb 04, 2025

Simulations Plus to Participate in Upcoming Healthcare Investor Conferences - BioSpace

Feb 04, 2025
pulisher
Feb 04, 2025

Biotech Leader Simulations Plus Sets Stage for Major Investor Showcase at Premier Healthcare Conferences - StockTitan

Feb 04, 2025
pulisher
Feb 03, 2025

William Blair Issues Pessimistic Outlook for SLP Earnings - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Q1 EPS Estimates for Simulations Plus Cut by William Blair - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of “Buy” from Analysts - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

SG Americas Securities LLC Has $698,000 Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World

Jan 31, 2025
pulisher
Jan 31, 2025

William Blair Issues Pessimistic Estimate for SLP Earnings - Defense World

Jan 31, 2025
pulisher
Jan 26, 2025

KeyCorp Forecasts Strong Price Appreciation for Simulations Plus (NASDAQ:SLP) Stock - Defense World

Jan 26, 2025
pulisher
Jan 25, 2025

Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Tributary Capital Management LLC - MarketBeat

Jan 25, 2025
pulisher
Jan 24, 2025

JPMorgan Chase & Co. Boosts Stake in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World

Jan 24, 2025
pulisher
Jan 22, 2025

Simulations Plus, Inc. and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus®? Enhancements - Marketscreener.com

Jan 22, 2025
pulisher
Jan 22, 2025

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements - Business Wire

Jan 22, 2025
pulisher
Jan 20, 2025

Simulations Plus (SLP) to Report Q2 Earnings: What's in Store? - MSN

Jan 20, 2025
pulisher
Jan 16, 2025

World Bank warns that US tariffs could reduce global growth outlook -January 16, 2025 at 01:03 pm EST - Marketscreener.com

Jan 16, 2025
pulisher
Jan 15, 2025

There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings - Yahoo Finance

Jan 15, 2025
pulisher
Jan 15, 2025

Simulations Plus Inc (SLP) Stock Price Down 3.84% on Jan 14 - GuruFocus.com

Jan 15, 2025
pulisher
Jan 15, 2025

Barclays PLC Has $911,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

Barclays PLC Grows Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat

Jan 15, 2025
pulisher
Jan 13, 2025

Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 - Business Wire

Jan 13, 2025
pulisher
Jan 13, 2025

US Growth Companies With High Insider Ownership In January 2025 - Simply Wall St

Jan 13, 2025
pulisher
Jan 13, 2025

Simulations Plus Powers 100% of FDA-Approved Drugs in 2024 with AI-Driven Solutions - StockTitan

Jan 13, 2025
pulisher
Jan 11, 2025

Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y - MSN

Jan 11, 2025
pulisher
Jan 11, 2025

William Blair Has Pessimistic Outlook of SLP Q2 Earnings - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

Conestoga Capital Advisors, LLC Expands Stake in Simulations Plu - GuruFocus.com

Jan 10, 2025
pulisher
Jan 10, 2025

William Blair Issues Pessimistic Forecast for SLP Earnings - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

KeyCorp Has Lowered Expectations for Simulations Plus (NASDAQ:SLP) Stock Price - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

William Blair Issues Optimistic Outlook for SLP Earnings - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Receives $51.40 Average Price Target from Brokerages - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Simulations Plus First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Jan 09, 2025
pulisher
Jan 08, 2025

Simulations Plus's SWOT analysis: bio-simulation leader faces growth challenges - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus (NASDAQ:SLP) Price Target Cut to $35.00 by Analysts at KeyCorp - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus Inc (NASDAQ:SLP) Lags Earning Estimates - FXDailyReport.com

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus (NASDAQ:SLP) Sets New 12-Month LowTime to Sell? - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus' (SLP) "Outperform" Rating Reaffirmed at William Blair - MarketBeat

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus stock affirmed at Outperform on Q1 report By Investing.com - Investing.com Canada

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus Inc. (SLP) reports earnings - Quartz

Jan 08, 2025
pulisher
Jan 08, 2025

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal - Simply Wall St

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus: Fiscal Q1 Earnings Snapshot - mySA

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus earnings beat by $0.03, revenue topped estimates - Investing.com Canada

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Str - GuruFocus.com

Jan 08, 2025
pulisher
Jan 08, 2025

Simulations Plus Inc (SLP) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance

Jan 08, 2025

Simulations Plus Inc Stock (SLP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Simulations Plus Inc Stock (SLP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
WOLTOSZ WALTER S
Director
Jan 02 '25
Sale
27.88
20,000
557,662
3,422,584
$13.61
price up icon 0.00%
$12.95
price up icon 8.19%
$22.50
price down icon 0.84%
$22.11
price down icon 1.60%
health_information_services WAY
$40.93
price down icon 0.02%
health_information_services HQY
$111.52
price down icon 0.49%
Cap:     |  Volume (24h):